Margaret Krackeler, MD

Margaret Krackeler, MD, is a hematologist/oncologist at Kaiser Permanente of Northern California.

Articles by Margaret Krackeler, MD

The Value of Real-World Data in CLL: Margaret Krackeler, MD

February 4th 2026

Margaret Krackeler, MD, of Kaiser Permanente Northern California, discusses the growing role of real-world treatment data in CLL and other cancers.

Real-World Data Support Zanubrutinib Use in Older Patients With CLL: Margaret Krackeler, MD

ByRose McNulty,Margaret Krackeler, MD

January 31st 2026

Margaret Krackeler, MD, discusses real-world data supporting the switch from ibrutinib to zanubrutinib for chronic lymphocytic leukemia.

Perspectives on Zanubrutinib Adoption for CLL Treatment: Margaret Krackeler, MD

ByRose McNulty,Margaret Krackeler, MD

January 29th 2026

Adopting zanubrutinib for the treatment of chronic lymphocytic leukemia showed improved tolerability and persistence, enhancing patient safety and outcomes.

Margaret Krackeler, MD

Articles by Margaret Krackeler, MD

The Value of Real-World Data in CLL: Margaret Krackeler, MD

Real-World Data Support Zanubrutinib Use in Older Patients With CLL: Margaret Krackeler, MD

Perspectives on Zanubrutinib Adoption for CLL Treatment: Margaret Krackeler, MD

Latest Updated Articles

Trending on AJMC

Howard A. “Skip” Burris, III, MD: An Oncology Pioneer Reflects on Patients, Progress, and Purpose

New Bill Makes CMS Enforcer in PBM, Pharmacy Relationship: A Q&A With Jesse Dresser, Esq

Asundexian Cuts Recurrent Stroke Risk Without More Bleeding: Mukul Sharma, MD, MSc

Faricimab Safe, Effective for Use in Treating nAMD in Treatment-Naive Eyes

Debunking Myths to Boost Clinical Trial Enrollment Diversity: Susan Vadaparampil, PhD, MPH